Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • duplicate reads in enriched samples

    Hi all,
    I have some RNAseq data (enriched and non-enriched) generated on Illumina. I am seeing a lot of duplicate reads (as well as much higher read depth) in the enriched dataset. Does enrichment result in excess duplicate reads? If yes, what is the best way to deal with them.

    Thanks in advance for your help.



    P.S. I have been reading SEQanswers for a while now. It is an excellent source of information.

  • #2
    Originally posted by ngs_agd View Post
    Hi all,
    I have some RNAseq data (enriched and non-enriched) generated on Illumina. I am seeing a lot of duplicate reads (as well as much higher read depth) in the enriched dataset. Does enrichment result in excess duplicate reads? If yes, what is the best way to deal with them.

    Thanks in advance for your help.



    P.S. I have been reading SEQanswers for a while now. It is an excellent source of information.
    I'm interesting in this issue too, in our target resequencing experiment we detected a wide range of % in duplicates (from 2 to 80 %). Is it normal that in a target reseq experiment % of duplicates raise?

    Comment


    • #3
      I said in another thread that I communicated by email with an Agilent rep and the main determining factor to duplicates is the number of PCR cycles pre-hybridization. With 7 or 8 cycles I see < 5% duplicates.

      Comment


      • #4
        Thanks for your reply Heisman, next time will decrease number of cycles!

        Comment

        Latest Articles

        Collapse

        • seqadmin
          Understanding Genetic Influence on Infectious Disease
          by seqadmin




          During the COVID-19 pandemic, scientists observed that while some individuals experienced severe illness when infected with SARS-CoV-2, others were barely affected. These disparities left researchers and clinicians wondering what causes the wide variations in response to viral infections and what role genetics plays.

          Jean-Laurent Casanova, M.D., Ph.D., Professor at Rockefeller University, is a leading expert in this crossover between genetics and infectious...
          09-09-2024, 10:59 AM
        • seqadmin
          Addressing Off-Target Effects in CRISPR Technologies
          by seqadmin






          The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...
          08-27-2024, 04:44 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by seqadmin, Yesterday, 02:44 PM
        0 responses
        8 views
        0 likes
        Last Post seqadmin  
        Started by seqadmin, 09-06-2024, 08:02 AM
        0 responses
        143 views
        0 likes
        Last Post seqadmin  
        Started by seqadmin, 09-03-2024, 08:30 AM
        0 responses
        151 views
        0 likes
        Last Post seqadmin  
        Started by seqadmin, 08-27-2024, 04:40 AM
        0 responses
        158 views
        0 likes
        Last Post seqadmin  
        Working...
        X